Lung Density Analysis II Workflow | TeraRecon

Fast Access to Lung Quantification Results & Tissue Characterization

Current lung quantification and segmentation workflows are not specific to recent unique disease presentation.
Physicians need a fast way to identify affected lung tissue and viable lung capacity of infected patients.
Physicians can more quickly & effectively identify disease impact, determine progression or improvement, and suggest additional or follow-up treatment required for better patient outcomes.

*The following are important statements regarding the use of this tool:

Volumetric histogram and lung segmentation functionality are FDA cleared features of Intuition. This functionality is not FDA cleared specifically for COVID-19. It must only be used as an aid and that final interpretation should be performed by a licensed healthcare practitioner with the appropriate training.
The results should not be used for screening and the software does not provide specific disease detection and should not be solely or primarily relied upon to diagnose or treat COVID-19.
This device is not indicated for the diagnosis of COVID-19 and that in vitro diagnostic testing is currently the only definitive method to diagnose COVID-19.
This tool is available by specific licenses only.
The default thresholds are generalized recommendations and limits for device performance when used in an U.S. population. The image analysis should only be used as an aid and the final interpretation should be performed by a licensed healthcare practitioner with the appropriate training.